{"messages":[{"status":"ok","cursor":"5220","count":30,"total":8966}], "collection":[{"rel_doi":"10.1101\/2020.05.16.20103903","rel_title":"Causal Modeling of Twitter Activity During COVID-19","rel_date":"2020-05-20","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.16.20103903","rel_abs":"Understanding the characteristics of public attention and perception is an essential prerequisite for appropriate crisis management during adverse health events. This is even more crucial during a pandemic such as COVID-19, as primary responsibility of risk management is not centralized to a single institution, but distributed across society. While numerous studies utilize Twitter data in descriptive or predictive context during COVID-19 pandemic, causal modeling of public attention has not been investigated. In this study, we propose a causal inference approach to discover and quantify causal relationships between pandemic characteristics (e.g. number of infections and deaths) and Twitter activity as well as public sentiment. Our results show that the proposed method can successfully capture the epidemiological domain knowledge and identify variables that affect public attention and perception. We believe our work contributes to the field of infodemiology by distinguishing events that correlate with public attention from events that cause public attention.","rel_num_authors":2,"rel_authors":[{"author_name":"Oguzhan Gencoglu","author_inst":"Tampere University"},{"author_name":"Mathias Gruber","author_inst":"-"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"health informatics"},{"rel_doi":"10.1101\/2020.05.16.20103838","rel_title":"Preliminary evaluation of COVID-19 disease outcomes, test capacities and management approaches among African countries.","rel_date":"2020-05-20","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.16.20103838","rel_abs":"Background: Following the declaration of COVID-19 as a global pandemic and the report of index case in Africa, the number of countries in Africa with confirmed cases of the infection has grown tremendously with disease now being reported in almost all countries on the continent, with the exemption of Lesotho after 75 days. It is therefore necessary to evaluate the disease outcomes among the African countries as the situation unfolds for early identification of best practices for adoption. Methods: In this study, COVID-19 disease outcomes (confirmed cases, deaths and recoveries), testing capacities and disease management approaches among African countries were evaluated. The relationship between COVID-19 infections in African countries and their performance on global resilient indices including the Human Development Index (HDI), performance on Sustainable Development Goals (SDGs) and the Global Risk Index (GRI) were also examined. Data acquired from various standard databases were evaluated over a period of 75 days from the date of reporting the index case. Results: This study has revealed compelling spatial differences in the incidence, deaths and recoveries from COVID-19 among African countries. Egypt, South Africa, Morocco and Algeria were clustered as countries with highest values of COVID-19 disease outcomes on the continent during the 75-day period of observation. The cluster analysis and comparison of countries in terms of percentage recovered cases of confirmed infections revealed that Mauritius, Mauritania, Gambia, Burkina Faso, Madagascar, Togo and Uganda had the highest scores. Comparative analysis of COVID-19 across the world revealed that the parameters were relatively inconsequential in Oceania and Africa continents, while Europe, North America and Asia had significantly higher cases of disease outcomes. For COVID-19 testing capacities, South Africa, Ghana and Egypt are leading in total number of tests carried out. However when the number of tests carried out were related to population number of the countries, Djibouti, Mauritius, Ghana and South Africa are found to be the leading countries. With respect to management of the disease in Africa, all the countries adopted the WHO protocols, personal hygiene, economic palliatives and social distancing measures. Only three countries in Africa (Madagascar, Togo and Burkina Faso) had a state supported initiative to utilise traditional medicines or herbs as alternatives to control COVID-19. Additionally, most of the countries are providing prompt treatment of the patients with a range of drugs especially Hydroxychloroquine, Chloroquine and Chloroquine-Azithromycin combination. The study found that no strong relationship currently exists between the global resilient indicators (HDI, SDG and GRI) and COVID-19 cases across Africa. Conclusions: This study has revealed compelling spatial differences in disease outcomes among African countries and also found testing capacities for COVID-19 to be abysmally low in relation to the population. During the 75 days of observation, African countries have recorded significantly low number of deaths associated with COVID-19 and relatively high recovery rates. Countries in Africa with higher rate of recovery from the disease were found to have adopted strict adherence to some of WHO protocol to contain the disease, isolate all those who test positive to the disease and provide prompt treatment of the patients with a range of drugs especially Hydroxychloroquine, Chloroquine and Chloroquine-Azithromycin combination. The study recommends that the approaches adopted by the African countries which achieved high recovery rates from COVID-19 should be integrated into healthcare management plans for the disease across the continent even as the situation unfolds.","rel_num_authors":17,"rel_authors":[{"author_name":"Adebayo A Otitoloju","author_inst":"Department of Zoology, Ecotoxicology & Conservation Unit, University of Lagos"},{"author_name":"Esther O Oluwole","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Kafilat A Bawa-Allah","author_inst":"Department of Zoology, Ecotoxicology &  Conservation Unit, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Mayowa J Fasona","author_inst":"Department of Geography, Faculty of Social Sciences, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Ifeoma P Okafor","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Chukwuemeka Isanbor","author_inst":"Department of Chemistry, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Vincent O Osunkalu","author_inst":"Department of Haematology &  Blood Transfusion, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Abimbola A Sowemimo","author_inst":"Department of Pharmacognosy, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Obafemi A Keshinro","author_inst":"Academic Planning Unit, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Idowu A Aneyo","author_inst":"Department of Zoology, Ecotoxicology & Conservation Unit, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Olawale S Folarin","author_inst":"Department of Zoology, Ecotoxicology &  Conservation Unit, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Akinbami A Oladokun","author_inst":"Department of Zoology, Ecotoxicology &  Conservation Unit, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Oluwatosin J Akinsola","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Christianah I Ayolabi","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Tenny O Egwuatu","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Victor A Owoyomi","author_inst":"Department of Sociology, Faculty of Social Sciences, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Anthony E Ogbeibu","author_inst":"Department of Animal and Environmental Biology, Faculty of Life Sciences, University of Benin, Benin City, Edo State, Nigeria"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.16.20104141","rel_title":"Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy","rel_date":"2020-05-20","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.16.20104141","rel_abs":"Background: Hydroxychloroquine is currently being tested as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19) in several ongoing clinical trials. Objective: To compare the incidence of COVID-19 in Spanish patients with autoimmune rheumatic diseases treated with and without hydroxychloroquine. Methods: Retrospective electronic record review, from February 27th to April 16th, of patients with autoimmune inflammatory diseases followed at two academic tertiary care hospitals in Seville, Spain. The cumulative incidence of COVID-19, confirmed or suspected, was compared between patients with and without hydroxychloroquine as part of their treatment of autoimmune inflammatory diseases. Results: Among 722 included subjects, 290 (40%) were receiving hydroxychloroquine. During the seven-week study period, five (1.7% [95% CI: 0.5%-4.0%] cases of COVID-19 were registered among patients with hydroxychloroquine and five (1.2% [0.4%-2.7%]) (p=0.523) in without hydroxychloroquine. COVID-19 was confirmed by PCR in one (0.3%, 95% CI 0.008-1.9%) patient with hydroxychloroquine and two (0.5%, 95% CI 0.05%-1.6%) without hydroxychloroquine (p=1.0). One patient on hydroxychloroquine and two subjects without hydroxychloroquine were admitted to the hospital, none of them required to be transferred to the intensive care unit and no patient died during the episode. Conclusions: The incidence and severity of COVID-19 among patients with autoimmune rheumatic diseases with and without hydroxychloroquine was not significantly different. Hydroxychloroquine does not seem to be an appropriate therapy for post-exposure prophylaxis against COVID-19.","rel_num_authors":12,"rel_authors":[{"author_name":"Juan Macias","author_inst":"Hospital Universitario de Valme"},{"author_name":"Paz Gonzalez-Moreno","author_inst":"Hospital Universitario Virgen Macarena"},{"author_name":"Esther Sanchez-Garcia","author_inst":"Hospital Universitario de Valme"},{"author_name":"Ramon Morillo-Verdugo","author_inst":"Hospital Universitario de Valme"},{"author_name":"Carmen Dominguez-Quesada","author_inst":"Hospital Universitario Virgen Macarena"},{"author_name":"Ana Pinilla","author_inst":"Hospital Universitario de Valme"},{"author_name":"MaMar Macho","author_inst":"Hospital Universitario de Valme"},{"author_name":"MaVictoria Martinez","author_inst":"Hospital Universitario de Valme"},{"author_name":"Alejandro Gonzalez-Serna","author_inst":"Hospital Universitario de Valme"},{"author_name":"Anais Corma","author_inst":"Hospital Universitario de Valme"},{"author_name":"Luis Miguel Real","author_inst":"Hospital Universitario de Valme"},{"author_name":"Juan Antonio Pineda","author_inst":"Hospital Universitario de Valme"},{"author_name":"Oluwatosin J Akinsola","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Christianah I Ayolabi","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Tenny O Egwuatu","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Victor A Owoyomi","author_inst":"Department of Sociology, Faculty of Social Sciences, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Anthony E Ogbeibu","author_inst":"Department of Animal and Environmental Biology, Faculty of Life Sciences, University of Benin, Benin City, Edo State, Nigeria"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.12.20099044","rel_title":"Forecasting the COVID-19 Pandemic with Climate Variables for Top Five Burdening and Three South Asian Countries","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20099044","rel_abs":"Background: The novel coronavirus (COVID-19) is now in a horrific situation around the world. Prediction about the number of infected and death cases may help to take immediate action to prevent the epidemic as well as control the situation of a country. The ongoing debate about the climate factors may need more validation with more studies. The climate factors of the top-five affected countries and three south Asian countries have considered in this study to have a real-time forecast and robust validation about the impact of climate variables. Methods: The ARIMA model have included to model the univariate cumulative confirmed and death cases separately. The MLP, ELM and likelihood-based GLM count time series also considered as they consider the external variables as exogenous regressors. As the death count includes zero itself, zero-inflated count time series model has included instead of likelihood-based GLM. The better fitting of the ARIMA model will validate the underwhelm of meteorological factors was the initial hypothesis. The best model has identified through the application and comparison with the real data points. Results: The results depict that there is an influence of meteorological variables like temperature and humidity mostly for all the selected countries cumulative confirm cases excluding Italy and Sri-Lanka. However, the best models for deaths count of each country also identify the impact of meteorological variables for each country. Conclusion: The authors make the sixty days ahead forecast for each country which will be beneficial for the policymakers.","rel_num_authors":4,"rel_authors":[{"author_name":"Md. Karimuzzaman","author_inst":"Jahangirnagar University"},{"author_name":"Sabrina Afroz","author_inst":"Jahangirnagar University"},{"author_name":"Md. Moyazzem Hossain","author_inst":"Newcastle University"},{"author_name":"Azizur Rahman","author_inst":"Charles Sturt University"},{"author_name":"Carmen Dominguez-Quesada","author_inst":"Hospital Universitario Virgen Macarena"},{"author_name":"Ana Pinilla","author_inst":"Hospital Universitario de Valme"},{"author_name":"MaMar Macho","author_inst":"Hospital Universitario de Valme"},{"author_name":"MaVictoria Martinez","author_inst":"Hospital Universitario de Valme"},{"author_name":"Alejandro Gonzalez-Serna","author_inst":"Hospital Universitario de Valme"},{"author_name":"Anais Corma","author_inst":"Hospital Universitario de Valme"},{"author_name":"Luis Miguel Real","author_inst":"Hospital Universitario de Valme"},{"author_name":"Juan Antonio Pineda","author_inst":"Hospital Universitario de Valme"},{"author_name":"Oluwatosin J Akinsola","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Christianah I Ayolabi","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Tenny O Egwuatu","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Victor A Owoyomi","author_inst":"Department of Sociology, Faculty of Social Sciences, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Anthony E Ogbeibu","author_inst":"Department of Animal and Environmental Biology, Faculty of Life Sciences, University of Benin, Benin City, Edo State, Nigeria"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.12.20098962","rel_title":"Experience of quantitative SARS-CoV-2 antibody screening of health-care workers in the southern part of Kyoto city during COVID-19 peri-pandemic period","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20098962","rel_abs":"Background: The coronavirus disease-2019 (COVID-19) pandemic is associated with a heavy burden on the mental and physical health of patients, regional healthcare resources, and global economic activity. While our understanding of the incidence and case-fatality rates increases, data on seroprevalence of antibodies against the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in healthcare workers during the peri-pandemic period is insufficient. This study quantitatively evaluated seroprevalence of SARS-CoV-2 antibody in healthcare workers in the southern part of Kyoto city, Japan. Methods: We prospectively recruited healthcare workers from a single hospital between April 10 and April 20, 2020. We collected serum samples from these participants and quantitatively evaluated SARS-CoV-2 IgG antibody levels by enzyme-linked immunosorbent assay. Results: Five (5.4%), 15 (16.3%), and 72 (78.3%) participants showed positive, borderline, and negative serum SARS-CoV-2 IgG antibody status, respectively. We found the mean titer associated with each antibody status (overall, positive, borderline, and negative) was clearly differentiated. Participants working at the otolaryngology department and\/or having a history of seasonal common cold symptoms had a significantly higher titer of SARS-CoV-2 IgG antibody (p=0.046, p=0.046, respectively). Conclusions: Five (5.4%) and 15 (16.3%) participants tested positive and borderline, respectively, for SARS-CoV-2 IgG antibody during the COVID-19 peri-pandemic period. These rates were higher than expected based on government situation reports. The present findings suggest that COVID-19 was already spread in the southern part of Kyoto city at the early stage of pandemic.","rel_num_authors":8,"rel_authors":[{"author_name":"Kohei Fujita","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Shinpei Kada","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Osamu Kanai","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Hiroaki Hata","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Takao Odagaki","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Noriko Satoh-Asahara","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Tetsuya Tagami","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Akihiro Yasoda","author_inst":"NHO Kyoto Medical Center"},{"author_name":"Alejandro Gonzalez-Serna","author_inst":"Hospital Universitario de Valme"},{"author_name":"Anais Corma","author_inst":"Hospital Universitario de Valme"},{"author_name":"Luis Miguel Real","author_inst":"Hospital Universitario de Valme"},{"author_name":"Juan Antonio Pineda","author_inst":"Hospital Universitario de Valme"},{"author_name":"Oluwatosin J Akinsola","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Christianah I Ayolabi","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Tenny O Egwuatu","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Victor A Owoyomi","author_inst":"Department of Sociology, Faculty of Social Sciences, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Anthony E Ogbeibu","author_inst":"Department of Animal and Environmental Biology, Faculty of Life Sciences, University of Benin, Benin City, Edo State, Nigeria"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.15.20103119","rel_title":"Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.15.20103119","rel_abs":"Background COVID19 case fatality rate in hospitalized patients varies across countries and studies, but reliable estimates specific for age, sex, and comorbidities are needed to design trials for COVID19 interventions. Aim of this study is to provide population-based survival curves of hospitalized COVID19 patients. Methods A cohort study was conducted in Lombardy, Veneto, and Reggio Emilia using COVID19 registries linked to hospital discharge databases containing patient clinical histories. All patients with positive SARS CoV 2 RTPCR test on oral\/nasopharyngeal swabs hospitalized from 21st February to 21st April 2020 were identified. Kaplan Meier survival estimates were calculated at 14 and 30 days for death in any setting, stratifying by age, sex and Charlson Index. Findings Overall 42,926 hospitalized COVID19 patients were identified. Patients' median age was 69 years (IQR: 57; 79), 62.6% were males, 69.4% had a Charlson Index of 0. In total, 11,205 (26.1%) patients died over a median follow-up of 24 days (IQR: 10; 35). Survival curves showed that 22.0% of patients died within 14 days and 27.6% within 30 days of hospitalization. Survival was higher in younger patients and in females. Younger patients with comorbidities had a lower survival than older ones with comorbidities. Interpretation Over 27% of hospitalized COVID19 patients died within one month in three areas of Northern Italy that were heavily affected by SARS CoV 2 infection. Such a high fatality rate suggests that trials should focus on survival and have follow-up of at least one month.","rel_num_authors":11,"rel_authors":[{"author_name":"Paolo Giorgi Rossi","author_inst":"Azienda Unita' Sanitaria Locale  IRCCS di Reggio Emilia, Italy"},{"author_name":"Eliana Ferroni","author_inst":"Azienda Zero of the Veneto Region, Padua, Italy"},{"author_name":"Stefania Spila Alegiani","author_inst":"Italian National Institute of Health, National Center for Drug Research and Evaluation, Rome, Italy"},{"author_name":"Olivia Leoni","author_inst":"Department of Health of Lombardy Region, Milan, Italy"},{"author_name":"Gisella Pitter","author_inst":"Azienda Zero of the Veneto Region, Padua, Italy"},{"author_name":"Danilo Cereda","author_inst":"Department of Health of Lombardy Region, Milan, Italy"},{"author_name":"Massimiliano Marino","author_inst":"Azienda Unita' Sanitaria Locale  IRCCS, Reggio Emilia, Italy"},{"author_name":"Michele Pellizzari","author_inst":"Azienda Zero of the Veneto Region, Padua, Italy"},{"author_name":"Janet Sultana","author_inst":"Department of Biomedical and Dental Sciences and Morphofunctional Imaging  University of Messina, Messina, Italy"},{"author_name":"Gianluca Trifiro'","author_inst":"Department of Biomedical and Dental Sciences and Morphofunctional Imaging University of Messina, Messina, Italy"},{"author_name":"Marco Massari","author_inst":"Pharmacoepidemiology Unit  Italian National Institute of Health, Rome, Italy"},{"author_name":"Juan Antonio Pineda","author_inst":"Hospital Universitario de Valme"},{"author_name":"Oluwatosin J Akinsola","author_inst":"Department of Community Health &  Primary Care, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria"},{"author_name":"Christianah I Ayolabi","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Tenny O Egwuatu","author_inst":"Department of Microbiology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Victor A Owoyomi","author_inst":"Department of Sociology, Faculty of Social Sciences, University of Lagos, Akoka, Lagos, Nigeria"},{"author_name":"Anthony E Ogbeibu","author_inst":"Department of Animal and Environmental Biology, Faculty of Life Sciences, University of Benin, Benin City, Edo State, Nigeria"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.14.20101972","rel_title":"AI-based multi-modal integration of clinical characteristics, lab tests and chest CTs improves COVID-19 outcome prediction of hospitalized patients","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20101972","rel_abs":"The SARS-COV-2 pandemic has put pressure on Intensive Care Units, and made the identification of early predictors of disease severity a priority. We collected clinical, biological, chest CT scan data, and radiology reports from 1,003 coronavirus-infected patients from two French hospitals. Among 58 variables measured at admission, 11 clinical and 3 radiological variables were associated with severity. Next, using 506,341 chest CT images, we trained and evaluated deep learning models to segment the scans and reproduce radiologists' annotations. We also built CT image-based deep learning models that predicted severity better than models based on the radiologists' reports. Finally, we showed that adding CT scan information-either through radiologist lesion quantification or through deep learning-to clinical and biological data, improves prediction of severity. These findings show that CT scans contain novel and unique prognostic information, which we included in a 6-variable ScanCov severity score.","rel_num_authors":48,"rel_authors":[{"author_name":"Nathalie Lassau","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Samy Ammari","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Emilie Chouzenoux","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugo Gortais","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre - AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Paul Herent","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Matthieu Devilder","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Samer Soliman","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.14.20102038","rel_title":"SARS-CoV-2 Detection in Different Respiratory Sites: A Systematic Review and Meta-Analysis","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20102038","rel_abs":"Background: The accurate detection of SARS-CoV-2 through respiratory sampling is critical for the prevention of further transmission and the timely initiation of treatment for COVID-19. There is a diverse range of SARS-CoV-2 detection rates in reported studies, with uncertainty as to the optimal sampling strategy for COVID-19 diagnosis and monitoring. Methods: We performed a systematic review and meta-analysis of studies comparing respiratory sampling strategies for the detection of SARS-CoV-2 RNA. The inclusion criteria were studies that assessed at least two respiratory sampling sites (oropharyngeal swab, nasopharyngeal swab, and sputum) in participants with COVID-19. The percentage positive tests were compared between sampling modalities by constructing a Z-test assuming independence and using the standard errors obtained from the random effects meta-analysis. Findings: From 1039 total studies, we identified 11 studies that met our inclusion criteria, with SARS-CoV-2 testing results from a total of 3442 respiratory tract specimens. Compared to nasopharyngeal swab sampling, sputum testing resulted in significantly higher rates of SARS-CoV-2 RNA detection while oropharyngeal swab testing had lower rates of viral RNA detection. Earlier sampling after symptom onset was associated with improved detection rates, but the differences in SARS-CoV-2 RNA detection by sampling method was consistent regardless of the duration of symptoms. Interpretation: The results support sputum sampling as a primary method of COVID-19 diagnosis and monitoring, and highlight the importance of early testing after symptom onset to increase the rates of COVID-19 diagnosis.","rel_num_authors":5,"rel_authors":[{"author_name":"Abbas Mohammadi","author_inst":"Brigham and Women`s Hospital"},{"author_name":"Elmira Esmaeilzadeh","author_inst":"Brigham and Women`s Hospital"},{"author_name":"Yijia Li","author_inst":"Brigham and Women`s Hospital"},{"author_name":"Ronald J Bosch","author_inst":"Harvard T.H. Chan School of Public Health"},{"author_name":"Jonathan Li","author_inst":"Brigham and Women`s Hospital"},{"author_name":"Matthieu Devilder","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Samer Soliman","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.14.20098608","rel_title":"VENTILATORY SUPPORT IN SARS-VOC-2 DURING INTENSIVE THERAPY","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20098608","rel_abs":"Introduction: The SARS-CoV-2 disease outbreak has now become a pandemic. Critical patients with COVID-19 require basic and advanced respiratory support. Therefore, the objective was to describe the ventilatory support strategies in SARS-CoV-2 during intensive therapy. Materials and methods: A systematic review of observational studies of the available scientific literature was performed in accordance with the recommendations of the Cochrane collaboration and the criteria of the PRISMA Declaration. Results: Fifteen observational studies were included that gave a study population of 4,081 patients. Mechanical ventilation is the main respiratory support treatment for critically ill patients, which should be administered as soon as normal oxygenation cannot be maintained, and despite the fact that there is no current consensus on the parameters of mechanical ventilation, the evidence collected suggests the use of Fio2 on average 50%, PEEP of 14 cmH2O, lung compliance of 29-37 ml per cm of water, driving pressure between 12-14 cm of water and a plateau pressure of 22-25 cm of water. Conclusions: IL-6 is shown as a possible marker of respiratory failure and a worse prognosis as well as obesity. In addition, the use of prone position, neuromuscular blockade, pulmonary vasodilators, ECMO, and mechanical ventilation based on the clinical conditions and needs of the patient with COVID-19 are strategies that could benefit patients entering intensive therapy for SARS-CoV- 2.","rel_num_authors":5,"rel_authors":[{"author_name":"Javier Eliecer Pereira Rodriguez","author_inst":"Hospital angeles lomas"},{"author_name":"Juan Camilo Quintero Gomez III","author_inst":"IPS Diversity Foundation."},{"author_name":"Otilio Lopez Florez Sr.","author_inst":"Hospital angeles lomas"},{"author_name":"Sandra Sharon Waiss Skvirsky Jr.","author_inst":"Hospital angeles lomas"},{"author_name":"Ximena Velasquez Badillo Jr.","author_inst":"Hospital angeles lomas"},{"author_name":"Matthieu Devilder","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Samer Soliman","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"intensive care and critical care medicine"},{"rel_doi":"10.1101\/2020.05.13.20100453","rel_title":"Mortality rates from COVID-19 in Spain and Italy, Lessons for the UK!","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100453","rel_abs":"The Covid-19 pandemic brings major new challenges to health services resulting from the lack of a vaccine and from the enormous resources it can consume over a prolonged period. The available control measures are currently limited to quarantining, contact tracking-and-tracing and social distancing. Disease transmission to health care workers is common and deaths among clinical and nursing staff have been reported in the UK (where serious concerns about the availability of personal protective equipment - PPE - have been raised) and elsewhere; particularly in Lombardy, where General Practitioners (Medici di Base) have died in disproportionate numbers.","rel_num_authors":4,"rel_authors":[{"author_name":"Adrian Davis","author_inst":"University College London, Ear Institute, UK"},{"author_name":"Irene Stratton","author_inst":"Gloucestershire Retinal Research Group, Cheltenham General Hospital, UK"},{"author_name":"Richard Quinton","author_inst":"Translational & Clinical Research Institute, University of Newcastle-upon-Tyne, UK"},{"author_name":"Graham Roberts","author_inst":"University College Cork, HRC-Clinical Research Facility, Republic of Ireland"},{"author_name":"Ximena Velasquez Badillo Jr.","author_inst":"Hospital angeles lomas"},{"author_name":"Matthieu Devilder","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Samer Soliman","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.15.20099465","rel_title":"Monitoring and predicting SARS-CoV-2 epidemic in France after deconfinement using a multiscale age-stratified rate model","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.15.20099465","rel_abs":"The entire world and France were strongly impacted by the SARS-COV-2 epidemic. Finding appropriate measures that effectively contain the spread of the epidemic without putting a too severe pressure on social and economic life is major challenge for modern predictive approaches. To assess the impact of confinement (March 17th till May 11th) and deconfinement, we develop a novel rate model to monitor and predict the spread of the epidemic and its impact on the health care system. The model accounts for age-dependent interactions between population groups and predicts consequences for various infection categories such as number of infected, hospitalized, load of intensive care units (ICU), number of death, recovered and more. We use online health care data for the five most infected regions of France to calibrate the model. At day of deconfinement (May 11th), we find that 13% (around 4.8M) of the population is infected in the five most affected regions of France (extrapolating to 5.8M for France). The model predicts that if the reproduction rate R0 is reduced by at least a factor of 2.5-3 for all age groups, which could be achieved by wearing masks and social distancing, a significant second peak could be prevented. However, if the reduction in R0 for the age group 0-25 would be less and below 2 (school openings), a second peak is unavoidable in which case the ICU will be saturated. In that context testing should be focused on children, but it will nevertheless have a limited impact on reducing the spread.","rel_num_authors":3,"rel_authors":[{"author_name":"Juergen Reingruber","author_inst":"Ecole Normale Superieure"},{"author_name":"Andrea Papale","author_inst":"ENS"},{"author_name":"David holcman","author_inst":"ENS"},{"author_name":"Graham Roberts","author_inst":"University College Cork, HRC-Clinical Research Facility, Republic of Ireland"},{"author_name":"Ximena Velasquez Badillo Jr.","author_inst":"Hospital angeles lomas"},{"author_name":"Matthieu Devilder","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Samer Soliman","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.13.20100222","rel_title":"Silent Disease and Loss of Taste and Smell are Common Manifestations of SARS-COV-2 Infection in a Quarantine Facility: First report from Saudi Arabia","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100222","rel_abs":"Abstract BACKGROUND The Coronavirus disease 2019 (COVID-19) outbreak in Saudi Arabia was first identified in a traveler from Al Qatif city, on March 2nd, 2020. The disease has quickly spread and reached multiple cities within a few weeks. In an attempt to limit the spread of COVID-19 in Saudi Arabia, the government has implemented strict regulations. Starting March 15th, all travelers coming back to the kingdom were tested for COVID-19 and were quarantined in a government-designated facility. The same rule was applied to all positive cases identified by contact tracing. In this study, we aimed to assess the prevalence of asymptomatic carriers, epidemiological characteristics, clinical presentations, and viral clearance of SARS-COV-2 positive quarantined individuals in a quarantine facility in the eastern province. METHODS We conducted a cross-sectional study on 128 laboratory-confirmed COVID-19 subjects who were quarantined in a government-designated facility. The study period was from March 16th until April 18th, 2020. We collected data on demographics and on clinical symptoms. Also, samples for PCR tests were collected upon admission and were repeated every 72 hours if they were still positive. All negative samples were repeated within 24 hours for confirmation. RESULTS Sixty-nine of the 128 residents (54%) were completely asymptomatic until the end of the study. The remaining 59 residents (46%) had only mild symptoms. The most common symptom was a sudden loss of smell and taste, accounting for 47.5%. The median time to virus clearance was significantly different between the two groups. Symptomatic residents cleared the virus at a median of 17 days (95% CI,12.4-21.6) from the first positive PCR vs. 11days (95% CI, 8.7-13.3) in the asymptomatic group (P=0.011). False-negative test results occurred in 18.8% of the total residents and false-positive results in 3%. CONCLUSION The prevalence of asymptomatic carriers is high in our study. Testing, and isolating travelers and contacts of laboratory-confirmed cases, regardless of symptoms, were very effective measures for early disease identification and containment. Loss of taste and smell was the most common presentation in our mild symptomatic residents, and it might be predictive of mild disease. The persistent positive PCRs observed in the mild asymptomatic residents despite being symptoms free, warrant further studies to determine its implications on disease spread and control.","rel_num_authors":7,"rel_authors":[{"author_name":"Alanoud A Alshami","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Rabab A Alattas","author_inst":"King Fahad Specialist Dammam"},{"author_name":"Hadeel F Anan","author_inst":"king Fahad Specialist Hospital"},{"author_name":"Hadi S Al Qahtani","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Mobarak A Al Mulhim","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Abdulbari A Alahilmi","author_inst":"King Faisal University in Al Ahsa"},{"author_name":"Ahmed H Alfaraj","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.13.20100255","rel_title":"Manifestations of mortality based global data of COVID-19; unifying global model through single parameter","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100255","rel_abs":"Critical inspection of the world data of COVID-19 mortality rates per population number has been made and used to express extensive variations in mortality over the globe in terms of a powered parameter {lambda} varying from 0 to 1.2 expressed as a measure of strength of primary infection, originating from China source. The copying process is degenerating successively while infection is passed on to secondary subjects. We have been able to correlate global data through this parameter; any value close to or less than 1 shows significant impact of diluted multiple secondary effect. Further, the scatter diagram shows no effect of temperature of the geographical location and so is likely as the virus is only being spread from either contact or close proximity; the virus does not need to face highs and lows of temperatures of the environment. It stays only in the range of human body temperature and appears to be stable in 36 to 40C range. If it faces the environmental temperatures it is possible for its quicker deactivation but that situation never arises for this virus except when it spreads from surfaces.","rel_num_authors":1,"rel_authors":[{"author_name":"Vijay K Jindal","author_inst":"Panjab University"},{"author_name":"Rabab A Alattas","author_inst":"King Fahad Specialist Dammam"},{"author_name":"Hadeel F Anan","author_inst":"king Fahad Specialist Hospital"},{"author_name":"Hadi S Al Qahtani","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Mobarak A Al Mulhim","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Abdulbari A Alahilmi","author_inst":"King Faisal University in Al Ahsa"},{"author_name":"Ahmed H Alfaraj","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.12.20098970","rel_title":"Agent-Based Simulation for Evaluation of Contact-Tracing Policies Against the Spread of SARS-CoV-2","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20098970","rel_abs":"The decline of active COVID-19 cases in many countries in the world has proved that lockdown policies are indeed a very effective measure to stop the exponential spread of the virus. Still, the danger of a second wave of infections is omnipresent and it is clear, that every policy of the lockdown has to be carefully evaluated and possibly replaced by a different, less restrictive policy, before it can be lifted. Tracing of contacts and consequential tracing and breaking of infection-chains is a promising and comparably straightforward strategy to help containing the disease, although its precise impact on the epidemic is unknown. In order to quantify the benefits of tracing and similar policies we developed an agent-based model that not only validly depicts the spread of the disease, but allows for exploratory analysis of containment policies. We will describe our model and perform case studies in which we use the model to quantify impact of contact tracing in different characteristics and draw valuable conclusions about contact tracing policies in general.","rel_num_authors":6,"rel_authors":[{"author_name":"Martin Richard Bicher","author_inst":"TU Wien"},{"author_name":"Claire Rippinger","author_inst":"dwh GmbH"},{"author_name":"Christoph Urach","author_inst":"dwh GmbH"},{"author_name":"Dominik Brunmeir","author_inst":"dwh GmbH"},{"author_name":"Uwe Siebert","author_inst":"UMIT University for Health Sciences, Institute of Public Health, Medical Decision Making and Health Technology Assessment"},{"author_name":"Niki Popper","author_inst":"TU Wien"},{"author_name":"Ahmed H Alfaraj","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.12.20099036","rel_title":"Stepping out of lockdown should start with school re-openings while maintaining distancing measures. Insights from mixing matrices and mathematical models.","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20099036","rel_abs":"Australia is one of a few countries which has managed to control COVID-19 epidemic before a major epidemic took place. Currently with just under 7000 cases and 100 deaths, Australia is seeing less than 20 new cases per day. This is a positive outcome, but makes estimation of current effective reproduction numbers difficult to estimate. Australia, like much of the world is poised to step out of lockdown and looking at which measures to relax first. We use age-based contact matrices, calibrated to Chinese data on reproduction numbers and difference in infectiousness and susceptibility of children to generate next generation matrices (NGMs) for Australia. These matrices have a spectral radius of 2.49, which is hence our estimated basic reproduction number for Australia. The effective reproduction number (Reff) for Australia during the April\/May lockdown period is estimated by other means to be around 0.8. We simulate the impact of lockdown on the NGM by first applying observations through Google Mobility Report for Australia at 3 locations: home (increased contacts by 18%), work (reduced contacts by 34%) and other (reduced contacts by 40%), and we reduce schools to 3% reflecting attendance rates during lockdown. Applying macro-distancing to the NGM leads to a spectral radius of 1.76. We estimate that the further reduction of the reproduction number to current levels of Reff = 0.8 is achieved by a micro-distancing factor of 0.26. That is, in a given location, people are 26% as likely as usual to have an effective contact with another person. We apply both macro and micro-distancing to the NGMs to examine the impact of different exit strategies. We find that reopening schools is estimated to reduce Reff from 0.8 to 0.78. This is because increase in school contact is offset by decrease in home contact. The NGMs all estimate that adults aged 30-50 are responsible for the majority of transmission. We also find that micro-distancing is critically important to maintain Reff <1. There is considerable uncertainty in these estimates and a sensitivity and uncertainty analysis is presented.","rel_num_authors":5,"rel_authors":[{"author_name":"Emma Sue McBryde","author_inst":"James Cook University"},{"author_name":"James M Trauer","author_inst":"Monash University"},{"author_name":"Adeshina Adekunle","author_inst":"James Cook University"},{"author_name":"Romain Ragonnet","author_inst":"Monash University"},{"author_name":"Michael T Meehan","author_inst":"James Cook University"},{"author_name":"Niki Popper","author_inst":"TU Wien"},{"author_name":"Ahmed H Alfaraj","author_inst":"King Fahad Specialist Hospital Dammam"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.14.20102012","rel_title":"Mental health in the UK during the COVID-19 pandemic: early observations","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20102012","rel_abs":"Background: Previous pandemics have resulted in significant consequences for mental health. Here we report the mental health sequela of the COVID-19 pandemic on the UK population and examine modifiable and non-modifiable explanatory factors associated with mental health outcomes. We focus on the short-term consequences for mental health, as reported during the first four-six weeks of social distancing measures being introduced. Methods: A community cohort study was conducted with adults aged [&ge;]18 years recruited through a mainstream and social media campaign between 3\/4\/20-30\/4\/20. Consenting participants completed an online survey measuring depression, anxiety and stress and explanatory variables hypothesised to be related to these mental health outcomes. Outcomes: N=3097 eligible individuals participated. The cohort was predominantly female (85%); mean age forty-four years; 10% from minority ethnic groups; 50% described themselves as key-workers and 20% identified as having clinical risk factors putting them at increased risk of COVID-19. Mean scores for depression, stress and anxiety significantly exceeded population norms. Analysis of non-modifiable factors indicated that being younger and female were associated with all outcomes, with the final multivariable models accounting for 7-13% of variance. When adding modifiable factors, significant independent effects emerged for positive mood, perceived loneliness and worry about getting COVID-19 for all outcomes, with the final multivariable models accounting for 54-57% of variance. Interpretation: Increased psychological morbidity was evident in this UK cohort, with younger people and women at particular risk. Interventions targeting perceptions of: loneliness, risk of COVID-19, worry about COVID-19, and positive mood may be effective.","rel_num_authors":7,"rel_authors":[{"author_name":"Ru Jia","author_inst":"Division of Primary Care, University of Nottingham"},{"author_name":"Kieran Ayling","author_inst":"Division of Primary Care, University of Nottingham"},{"author_name":"Trudie Chalder","author_inst":"Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London"},{"author_name":"Adam Massey","author_inst":"Division of Primary Care, University of Nottingham"},{"author_name":"Elizabeth Broadbent","author_inst":"Department of Psychological Medicine, University of Auckland"},{"author_name":"Carol Coupland","author_inst":"Division of Primary Care, University of Nottingham"},{"author_name":"Kavita Vedhara","author_inst":"Division of Primary Care, University of Nottingham"},{"author_name":"Olivier Meyrignac","author_inst":"Biomaps. UMR1281 INSERM.CEA.CNRS.Universite Paris Saclay. Villejuif, F-94805, France"},{"author_name":"Marie-Pauline Talabard","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Jean-Philippe Lamarque","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.05.14.20101998","rel_title":"Obesity and COVID-19: The role of visceral adipose tissue","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20101998","rel_abs":"INTRODUCTION: During the unprecedented health crisis of the COVID-19 pandemic it was suggested that obesity might aggravate severe acute respiratory syndrome coronavirus-2 (SARS CoV-2). Therefore, this study aims to investigate the association between Compute Tomography (CT)-based measurements of visceral and subcutaneous fat as measures of obesity and COVID-19 severity. METHODS: 30 patients with laboratory-confirmed COVID-19 and a mean age of 65.59 plus\/minus 13.06 years from a level one medical center in Berlin, Germany, were retrospectively analyzed and included in the present analysis. SARS-CoV-2 was confirmed by polymerase chain reaction from throat swaps or deep nasal swabs on the day of admission. Severe clinical courses of COVID-19 were defined by hospitalization in intensive care unit (ICU) and invasive mechanical ventilation. All patients received low-dose chest CT-based fat measurements at the level of the first lumbar vertebra. RESULTS: An increase in visceral fat area (VFA) by one square decimeter was associated with a 22.53-fold increased risk for ICU treatment and a 16.11-fold increased risk for mechanical ventilation (adjusted for age and sex). For upper abdominal circumference, each additional centimeter of circumference showed a 1.13-fold increased risk for ICU treatment and a 1.25-fold increased risk for mechanical ventilation. There was no significant correlation of subcutaneous fat area (SFA) or body mass index (BMI) with severe clinical courses of COVID-19. CONCLUSIONS: Our results suggest that visceral adipose tissue and upper abdominal circumference specifically increasing the risk of COVID-19 severity. CT-based quantification of visceral adipose tissue and upper abdominal circumference in routinely acquired chest CTs may therefore be a simple tool for risk assessment in SARS-CoV-2-patients.","rel_num_authors":10,"rel_authors":[{"author_name":"Antonia Petersen","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Keno Bressem","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Jakob Albrecht","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Hans-Martin Thiess","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Janis Vahldiek","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Bernd Hamm","author_inst":"Charite - Universitaetsmedizin Berlin, ChariteCentrum Diagnostische und interventionelle Radiologie und Nuklearmedizin CC 6"},{"author_name":"Marcus Makowski","author_inst":"Technical University of Munich, School of Medicine, Department of Diagnostic and  Interventional Radiology, 81675 Munich, Germany"},{"author_name":"Alexandra Niehues","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Stefan Niehues","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin - Department of Radiology, Hindenburgdamm 30, 12203 Berlin, Germany"},{"author_name":"Lisa Christine Adams","author_inst":"Charite - Universitaetsmedizin Berlin, Campus Charite Mitte - Department of Radiology, Chariteplatz 1, 10117 Berlin, Germany, Berlin Institute of Health (BIH), "},{"author_name":"Remy Dubois","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Nicolas Loiseau","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Trichelair","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Etienne Bendjebbar","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gabriel Garcia","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Corinne Balleyguier","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Mansouria Merad","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Annabelle Stoclin","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Simon Jegou","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Franck Griscelli","author_inst":"D\u00e9partement de Biologie, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Nicolas Tetelboum","author_inst":"Imaging Department Gustave Roussy. Universit\u00e9 Paris Saclay, Villejuif, F-94805, France"},{"author_name":"Yingping Li","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Sagar Verma","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Matthieu Terris","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Tasnim Dardouri","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Kavya Gupta","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Ana Neacsu","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Frank Chemouni","author_inst":"D\u00e9partement de Soins Intensifs, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Meriem Sefta","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Paul Jehanno","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Imad Bousaid","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Yannick Boursin","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Emmanuel Planchet","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Mikael Azoulay","author_inst":"Direction de la Transformation Num\u00e9rique et des Syst\u00e8mes d'Information, Gustave Roussy, 94800 Villejuif, France"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"radiology and imaging"},{"rel_doi":"10.1101\/2020.05.12.20094219","rel_title":"Factors affecting COVID-19 outcomes in cancer patients \t- A first report from Guys Cancer Centre in London","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20094219","rel_abs":"Background: There is insufficient evidence to support clinical decision-making for cancer patients diagnosed with COVID-19 due to the lack of large studies. Methods: We used data from a single large UK Cancer Centre to assess demographic\/clinical characteristics of 156 cancer patients with a confirmed COVID-19 diagnosis between 29 February-12 May 2020. Logistic\/Cox proportional hazards models were used to identify which demographic and\/or clinical characteristics were associated with COVID-19 severity\/death. Results: 128 (82%) presented with mild\/moderate COVID-19 and 28 (18%) with severe disease. Initial diagnosis of cancer >24m before COVID-19 (OR:1.74 (95%CI: 0.71-4.26)), presenting with fever (6.21 (1.76-21.99)), dyspnoea (2.60 (1.00-6.76)), gastro-intestinal symptoms (7.38 (2.71-20.16)), or higher levels of CRP (9.43 (0.73-121.12)) were linked with greater COVID-19 severity. During median follow-up of 47d, 34 patients had died of COVID-19 (22%). Asian ethnicity (3.73 (1.28-10.91), palliative treatment (5.74 (1.15-28.79), initial diagnosis of cancer >24m before (2.14 (1.04-4.44), dyspnoea (4.94 (1.99-12.25), and increased CRP levels (10.35 (1.05-52.21)) were positively associated with COVID-19 death. An inverse association was observed with increased levels of albumin (0.04 (0.01-0.04). Conclusions: A longer-established diagnosis of cancer was associated with increasing severity of infection as well as COVID-19 death, possibly reflecting effects of more advanced malignant disease impact on this infection. Asian ethnicity and palliative treatment were also associated with COVID-19 death in cancer patients.","rel_num_authors":34,"rel_authors":[{"author_name":"Beth Russell","author_inst":"King's College London"},{"author_name":"Charlotte Moss","author_inst":"King's College London"},{"author_name":"Sophie Papa","author_inst":"King's College London"},{"author_name":"Sheeba Irshad","author_inst":"King's College London"},{"author_name":"Paul Ross","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"James Spicer","author_inst":"King's College London"},{"author_name":"Shahram Kordasti","author_inst":"King's College London"},{"author_name":"Danielle Crawley","author_inst":"King's College London"},{"author_name":"Harriet Wylie","author_inst":"King's College London"},{"author_name":"Fidelma Cahill","author_inst":"King's College London"},{"author_name":"Anna Haire","author_inst":"King's College London"},{"author_name":"Kamarul Zaki","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Fareen Rahman","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Ailsa Lumsden","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Debra Josephs","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Deborah Enting","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Mary Lei","author_inst":"Guy''s and St Thomas' NHS Foundation Trust"},{"author_name":"Sharmistha Ghosh","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Claire Harrison","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Angela Swampillai","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Elinor Sawyer","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Andrea D'Souza","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Simon Gomberg","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Paul Fields","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"David Wrench","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Kavita Raj","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Mary Gleeson","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"oncology"},{"rel_doi":"10.1101\/2020.05.12.20098996","rel_title":"The Clinical and Economic Value of a Successful Shutdown During the SARS-CoV-2 Pandemic in Germany","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20098996","rel_abs":"Background and aim: Given a potential surge of COVID-19 cases in further pandemic waves, the German federal government and the German federal states have main-tained a partial shutdown of businesses. An important purpose of the shutdown is to avoid overstretching intensive care unit (ICU) capacity (\"flattening the curve\") at the height of the pandemic waves. The aim of this study was to determine the clinical and economic value of a successful shutdown. Methods: In the base case, the study compared a successful shutdown to a worst-case scenario with no ICU capacity left to treat COVID-19 patients. To this end, a decision model was developed using, e.g., information on age-specific fatality rates, ICU outcomes, and the herd protection threshold. The value of an additional life year was borrowed from new, innovative oncological drugs, as cancer reflects a condition with a similar morbidity and mortality burden in the general population in the short-term. Results: A successful shutdown is projected to yield an average gain between 0.02 and 0.08 life years (0.2 to 0.9 months) per capita in the German population. The cor-responding economic value ranges between 1543 and 8027 euros per capita or, extrap-olated to the total population, 4% to 19% of the gross domestic product in 2019. Nev-ertheless, if herd immunity is achieved through natural infection, even a shutdown that is successful in \"flattening the curve\" is expected to yield a loss of 0.42 life years per capita compared to the situation before the pandemic. Conclusion: A successful shutdown is forecasted to yield a considerable gain in life years in the German population. Nevertheless, questions around the affordability and underfunding of other parts of the healthcare system emerge.","rel_num_authors":1,"rel_authors":[{"author_name":"Afschin Gandjour","author_inst":"Frankfurt School of Finance & Management"},{"author_name":"Charlotte Moss","author_inst":"King's College London"},{"author_name":"Sophie Papa","author_inst":"King's College London"},{"author_name":"Sheeba Irshad","author_inst":"King's College London"},{"author_name":"Paul Ross","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"James Spicer","author_inst":"King's College London"},{"author_name":"Shahram Kordasti","author_inst":"King's College London"},{"author_name":"Danielle Crawley","author_inst":"King's College London"},{"author_name":"Harriet Wylie","author_inst":"King's College London"},{"author_name":"Fidelma Cahill","author_inst":"King's College London"},{"author_name":"Anna Haire","author_inst":"King's College London"},{"author_name":"Kamarul Zaki","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Fareen Rahman","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Ailsa Lumsden","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Debra Josephs","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Deborah Enting","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Mary Lei","author_inst":"Guy''s and St Thomas' NHS Foundation Trust"},{"author_name":"Sharmistha Ghosh","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Claire Harrison","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Angela Swampillai","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Elinor Sawyer","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Andrea D'Souza","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Simon Gomberg","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Paul Fields","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"David Wrench","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Kavita Raj","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Mary Gleeson","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"health economics"},{"rel_doi":"10.1101\/2020.05.15.20095927","rel_title":"Disparities in COVID-19 Reported Incidence, Knowledge, and Behavior","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.15.20095927","rel_abs":"Abstract Background: Data from the COVID-19 pandemic in the United States show large differences in hospitalizations and mortality across race and geography. However, there is limited data on health information, beliefs, and behaviors that might indicate different exposure to risk. Methods: A sample of 5,198 respondents in the United States (80% population representative, 20% oversample of hotspot areas in New York City, Seattle, New Orleans, and Detroit) was conducted from March 29th to April 13th to measure differences in knowledge, beliefs and behavior regarding COVID-19. Linear regression was used to understand racial, geographic, political, and socioeconomic differences in COVID-19 reported incidence knowledge, and behaviors after adjusting for state-specific and survey date fixed effects. Results: The largest differences in COVID-19 knowledge and behaviors are associated with race\/ethnicity, gender, and age. African-Americans, men, and people <55 years old are less likely to know how the disease is spread, less likely to know symptoms of COVID-19, wash their hands less frequently, and leave the home more often. Differences by income, political orientation, and living in a hotspot area are much smaller. Conclusions: There are wide gaps in COVID-19 reported incidence, knowledge regarding disease spread and symptoms, and in social distancing behavior. The findings suggest more effort is needed to increase accurate information and encourage appropriate behaviors among minority communities, men, and younger people.","rel_num_authors":4,"rel_authors":[{"author_name":"David Cutler","author_inst":"Harvard"},{"author_name":"Stefanie Stantcheva","author_inst":"Harvard"},{"author_name":"Marcella Alsan","author_inst":"Harvard"},{"author_name":"David Yang","author_inst":"Harvard"},{"author_name":"Paul Ross","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"James Spicer","author_inst":"King's College London"},{"author_name":"Shahram Kordasti","author_inst":"King's College London"},{"author_name":"Danielle Crawley","author_inst":"King's College London"},{"author_name":"Harriet Wylie","author_inst":"King's College London"},{"author_name":"Fidelma Cahill","author_inst":"King's College London"},{"author_name":"Anna Haire","author_inst":"King's College London"},{"author_name":"Kamarul Zaki","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Fareen Rahman","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Ailsa Lumsden","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Debra Josephs","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Deborah Enting","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Mary Lei","author_inst":"Guy''s and St Thomas' NHS Foundation Trust"},{"author_name":"Sharmistha Ghosh","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Claire Harrison","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Angela Swampillai","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Elinor Sawyer","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Andrea D'Souza","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Simon Gomberg","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Paul Fields","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"David Wrench","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Kavita Raj","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Mary Gleeson","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"health policy"},{"rel_doi":"10.1101\/2020.05.14.20100834","rel_title":"COVID-19 management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases centre: a detailed descriptive analysis","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20100834","rel_abs":"Background: Recent large national and international cohorts describe the baseline characteristics and outcome of hospitalised patients with COVID-19, however there is little granularity to these reports. We aimed to provide a detailed description of a UK COVID-19 cohort, focusing on clinical decisions and patient journeys. Methods: We retrospectively analysed the management and 28-day outcomes of 316 consecutive adult patients with SARS-CoV-2 PCR-confirmed COVID-19 admitted to a large NHS Foundation Trust with a tertiary High Consequence Infectious Diseases centre in the North of England. Findings: Most patients were elderly (median age 75) with multiple comorbidities. One quarter were admitted from residential or nursing care. Symptoms were consistent with COVID-19, with cough, fever and\/or breathlessness in 90.5% of patients. Two thirds of patients had severe disease on admission. Mortality was 81\/291 (27.8%). Most deaths were anticipated; decisions to initiate respiratory support were individualised after consideration of patient wishes, premorbid frailty and comorbidities, with specialist palliative care input where appropriate. 22\/291 (7.6%) patients were intubated and 11\/22 (50%) survived beyond discharge. Multiple logistic regression identified age as the most significant risk factor for death (OR 1.09 [95% CI 1.06 - 1.12] per year increase, p < 0.001). Interpretation: These findings provide important clinical context to outcome data. Deaths were anticipated, occurring in patients with advance decisions on ceilings of treatment. Age was the most significant risk factor for death, confirming that demographic factors in the population are a major influence on hospital mortality rates. Funding: Funding was not required.","rel_num_authors":27,"rel_authors":[{"author_name":"Kenneth F. Baker","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Aidan T. Hanrath","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Ina Schim van der Loeff","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Su Ann Tee","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Richard Capstick","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Gabriella Marchitelli","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ang Li","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Barr","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Alsafi Eid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Sajeel Ahmed","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Dalvir Bajwa","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Omer Mohammed","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Neil Alderson","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Clare Lendrem","author_inst":"NIHR In Vitro Diagnostics Cooperative, Newcastle University, UK"},{"author_name":"Dennis Lendrem","author_inst":"National Institute of Health Research (NIHR) Biomedical Research Centre, Newcastle University, UK"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.13.20100495","rel_title":"Risk factors for adverse clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100495","rel_abs":"Importance: COVID-19 is a clinically heterogeneous disease of varying severity and prognosis. Clinical characteristics that impact disease course could offer guidance for clinical decision making and future research endeavors and unveil disease pathways. Objective: To examine risk factors associated with adverse clinical outcomes in patients with COVID-19. Data sources: We performed a systematic review in PubMed from January 1 until April 19, 2020. Study selection: Observational studies that examined the association of any clinical characteristic with an adverse clinical outcome were considered eligible. We scrutinized studies for potential overlap. Data extraction and synthesis: Information on the effect of clinical factors on clinical endpoints of patients with COVID-19 was independently extracted by two researchers. When an effect size was not reported, crude odds ratios were calculated based on the available information from the eligible articles. Study-specific effect sizes from non-overlapping studies were synthesized applying the random-effects model. Main outcome and measure: The examined outcomes were severity and progression of disease, admission to ICU, need for mechanical ventilation, mortality, or a composite outcome. Results: We identified 88 eligible articles, and we performed a total of 256 meta-analyses on the association of 98 unique risk factors with five clinical outcomes. Seven meta-analyses presented the strongest epidemiological evidence in terms of statistical significance (P-value <0.005), between-study heterogeneity (I2 <50%), sample size (more than 1000 COVID-19 patients), 95% prediction interval excluded the null value, and absence of small-study effects. Elevated C-reactive protein (OR, 6.46; 95% CI, 4.85 - 8.60), decreased lymphocyte count (OR, 4.16; 95% CI, 3.17 - 5.45), cerebrovascular disease (OR, 2.84; 95% CI, 1.55 - 5.20), chronic obstructive pulmonary disease (OR, 4.44; 95% CI, 2.46 - 8.02), diabetes mellitus (OR, 2.04; 95% CI, 1.54 - 2.70), hemoptysis (OR, 7.03; 95% CI, 4.57 - 10.81), and male sex (OR, 1.51; 95% CI, 1.30 - 1.75) were associated with risk of severe COVID-19. Conclusions and relevance: Our results highlight factors that could be useful for prognostic model building, help guide patients' selection for randomized clinical trials, as well as provide alternative treatment targets by shedding light to disease pathophysiology.","rel_num_authors":4,"rel_authors":[{"author_name":"Vanesa Bellou","author_inst":"University of Ioannina Medical School"},{"author_name":"Ioanna Tzoulaki","author_inst":"University of Ioannina Medical School"},{"author_name":"Evangelos Evangelou","author_inst":"University of Ioannina Medical School"},{"author_name":"Lazaros Belbasis","author_inst":"University of Ioannina Medical School"},{"author_name":"Richard Capstick","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Gabriella Marchitelli","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ang Li","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Barr","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Alsafi Eid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Sajeel Ahmed","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Dalvir Bajwa","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Omer Mohammed","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Neil Alderson","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Clare Lendrem","author_inst":"NIHR In Vitro Diagnostics Cooperative, Newcastle University, UK"},{"author_name":"Dennis Lendrem","author_inst":"National Institute of Health Research (NIHR) Biomedical Research Centre, Newcastle University, UK"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.13.20100404","rel_title":"Clinical characteristics and early outcomes in patients with COVID-19 treated with tocilizumab at a United States academic center","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100404","rel_abs":"We describe early outcomes in 11 COVID-19 patients treated with the IL-6 receptor inhibitor tocilizumab. While C-reactive protein decreased, neither clinical improvement nor reduced temperature or oxygen requirements was observed in most patients. Our findings contrast with prior reports and raise questions about tocilizumab use in severe COVID-19.","rel_num_authors":15,"rel_authors":[{"author_name":"Casey Allison Rimland","author_inst":"Medical Scientist Training Program, University of North Carolina at Chapel Hill (UNC), Chapel Hill, NC"},{"author_name":"Camille E Morgan","author_inst":"Medical Scientist Training Program, University of North Carolina at Chapel Hill (UNC), Chapel Hill, NC; \tDepartment of Epidemiology, UNC Gillings School of Glob"},{"author_name":"Griffin J Bell","author_inst":"Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC"},{"author_name":"Min K Kim","author_inst":"Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"Tanner Hedrick","author_inst":"Department of Pharmacy, UNC Medical Center, Chapel Hill, NC"},{"author_name":"Ashley Marx","author_inst":"Department of Pharmacy, UNC Medical Center, Chapel Hill, NC"},{"author_name":"Brian Bramson","author_inst":"Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"Heidi Swygard","author_inst":"Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, NC, USA"},{"author_name":"Sonia Napravnik","author_inst":"Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC; Division of Infectious Diseases, Department of Medicine, UNC School of"},{"author_name":"John L Schmitz","author_inst":"Department of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"Shannon S Carson","author_inst":"Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"William A Fischer","author_inst":"Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"Joseph J Eron","author_inst":"Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"Cynthia L Gay","author_inst":"Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"Jonathan B Parr","author_inst":"Division of Infectious Diseases, Department of Medicine, UNC School of Medicine, Chapel Hill, NC"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.13.20100206","rel_title":"Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100206","rel_abs":"We prospectively compared the efficacy of PCR detection of SARS-CoV-2 between paired nasopharyngeal and saliva samples in 76 patients including ten COVID-19 patients. The overall concordance rate of the virus detection between the two samples was 97.4% (95%CI, 90.8-99.7). Viral load was equivalent in COVID-19 patients, but the virus tended to disappear earlier in saliva at convalescent phase compared to nasopharyngeal samples. These results suggest that saliva is a reliable noninvasive alternative to nasopharyngeal swabs and facilitate widespread PCR testing in the face of shortages of swabs and protective equipment without posing a risk to healthcare workers.","rel_num_authors":15,"rel_authors":[{"author_name":"Sumio Iwasaki","author_inst":"Hokkaido University"},{"author_name":"Shinichi Fujisawa","author_inst":"Hokkaido University"},{"author_name":"Sho Nakakubo","author_inst":"Hokkaido University"},{"author_name":"Keisuke Kamada","author_inst":"Hokkaido University"},{"author_name":"Yu Yamashita","author_inst":"Hokkaido University"},{"author_name":"Tatsuya Fukumoto","author_inst":"Hokkaido University"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.12.20099028","rel_title":"Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.12.20099028","rel_abs":"On March 28, 2020, in response to the rapidly accelerating COVID-19 pandemic, U.S FDA issued emergency use authorization for hydroxychloroquine (HCQ) in hospitalized COVID-19 patients based on limited in-vitro and anecdotal clinical data. Analysis of the accumulated real-world data utilizing electronic medical records (EMR) could indicate HCQ therapy benefits as we await the results of clinical trials. However, any such analysis of retrospective observational data should account for variables such as demographics and comorbidities that could affect treatment strategies or outcomes. Therefore, we report the outcomes of HCQ treatment in a propensity-matched cohort of COVID-19 hospitalized patients. Our analysis of a large retrospective cohort of hospitalized COVID-19 patients treated with HCQ did not show benefits in mortality or the need for mechanical ventilation when compared to a matched cohort of patients who did not receive HCQ.","rel_num_authors":4,"rel_authors":[{"author_name":"Shailendra Singh","author_inst":"Charleston Area Medical Center"},{"author_name":"Ahmad Khan","author_inst":"Department of Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, WV"},{"author_name":"Monica Chowdhry","author_inst":"Department of Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, WV"},{"author_name":"Arka Chatterjee","author_inst":"Division of Cardiovascular Disease, University of Alabama at Birmingham"},{"author_name":"Yu Yamashita","author_inst":"Hokkaido University"},{"author_name":"Tatsuya Fukumoto","author_inst":"Hokkaido University"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.05.13.20100743","rel_title":"Detecting the Emergent or Re-Emergent COVID-19 Pandemic in a Country: Modelling Study of Combined Primary Care and Hospital Surveillance","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100743","rel_abs":"Aims: We aimed to determine the effectiveness of surveillance using testing for SARS-CoV-2 to identify an outbreak arising from a single case of border control failure at a country level. Methods: A stochastic version of the SEIR model CovidSIM v1.1 designed specifically for COVID-19 was utilised. It was seeded with New Zealand (NZ) population data and relevant parameters sourced from the NZ and international literature. Results: For what we regard as the most plausible scenario with an effective reproduction number of 2.0, the results suggest that 95% of outbreaks from a single imported case would be detected in the period up to day 33 after introduction. At the time point of detection, there would be a median number of 6 infected cases in the community (95%UI: 1-68). To achieve this level of detection, an on-going programme of 7,800 tests per million people per week for the NZ population would be required. The vast majority of this testing (96%) would be of symptomatic cases in primary care settings and the rest in hospitals. Despite the large number of tests required, there are plausible strategies to enhance testing yield and cost-effectiveness eg, (i) adjusting the eligibility criteria via symptom profiles; (ii) and pooling of test samples. Conclusions: This model-based analysis suggests that a surveillance system with a very high level of routine testing is probably required to detect an emerging or re-emerging SARS-CoV-2 outbreak within one month of a border control failure in a nation.","rel_num_authors":6,"rel_authors":[{"author_name":"Nick Wilson","author_inst":"University of Otago, Wellington"},{"author_name":"Markus Schwehm","author_inst":"ExploSYS"},{"author_name":"Ayesha J Verrall","author_inst":"University of Otago, Wellington"},{"author_name":"Matthew Parry","author_inst":"University of Otago, Dunedin"},{"author_name":"Michael G Baker","author_inst":"University of Otago, Wellington"},{"author_name":"Martin Eichner","author_inst":"Epimos"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.13.20101089","rel_title":"Making sense of publicly available data on COVID-19 in Ireland","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20101089","rel_abs":"This paper reports on the management of the COVID19 pandemic in Ireland over the period March to May 2020. During this period the Irish government implemented a series of policies designed to delay the spread of the pandemic culminating in a stay-at-home order that greatly restricted mobility for the majority of the population. In this paper we evaluate the policies enacted using evidence obtained from a number of novel sources, including census and real-time traffic data. The evidence suggests that the policies have impeded the spread of the virus, which has mostly been confined to Dublin and its commuter belt. At the same time, the virus has become concentrated in a number of clusters associated with nursing homes and workplaces that remained open during the delay phase. This evidence is used to hypothesise on the likely impact of the pandemic on high density and poor neighbourhoods in Dublin.","rel_num_authors":4,"rel_authors":[{"author_name":"Gerald Mills","author_inst":"University College Dublin"},{"author_name":"Walter Cullen","author_inst":"UCD"},{"author_name":"Niamh Moore","author_inst":"UCD"},{"author_name":"Ronan Foley","author_inst":"Maynooth University"},{"author_name":"Michael G Baker","author_inst":"University of Otago, Wellington"},{"author_name":"Martin Eichner","author_inst":"Epimos"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.13.20100628","rel_title":"When strong mitigation against a pandemic backfires","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.13.20100628","rel_abs":"I introduce social feasibility constraints in a SIR epidemiological model: at any point in time, the ability of a social planner to impose mitigation measures is limited, but it is increasing in the proportion of infected individuals. When considering threshold policies with constant levels of mitigation for a time period, the overall fatality rate in the population is non-monotonic in the levels of mitigation: higher levels of mitigation can increase the overall fatality rate. Intuitively, strong mitigation at a point in time can undermine the social feasibility of future mitigation.","rel_num_authors":1,"rel_authors":[{"author_name":"Pierre Chaigneau","author_inst":"Queen's University"},{"author_name":"Walter Cullen","author_inst":"UCD"},{"author_name":"Niamh Moore","author_inst":"UCD"},{"author_name":"Ronan Foley","author_inst":"Maynooth University"},{"author_name":"Michael G Baker","author_inst":"University of Otago, Wellington"},{"author_name":"Martin Eichner","author_inst":"Epimos"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.05.15.20101097","rel_title":"Predictors of COVID-19 incidence, mortality, and epidemic growth rate at the country level","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.15.20101097","rel_abs":"Background. The burden of the coronavirus disease 2019 (COVID-19) pandemic has been geographically disproportionate. Certain weather factors and population characteristics are thought to drive transmission, but studies examining these factors are limited. We aimed to identify weather, sociodemographic, and geographic drivers of COVID-19 at the global scale using a comprehensive collection of country\/territory-level data, and to use discovered associations to estimate the timing of community transmission. Methods. We examined COVID-19 cases and deaths reported up to May 2, 2020 across 205 countries and territories in relation to weather data collected from capital cities for the eight weeks prior to and four weeks after the date of the first reported case, as well as country\/territory-level population, geographic, and planetary data. We performed univariable and multivariable regression modeling and odds ratio analyses to investigate associations with COVID-19 cases, deaths, and epidemic growth rate. We also conducted maximum likelihood analysis to estimate the timing of initial community spread. Findings. Lower temperature (p<0.0001), lower humidity (p=0.006), higher altitude (p=0.0080), higher percentage of urban population (p<0.0001), increased air travelers (p=0.00019), and higher prevalence of obesity (p<0.0001) were strong independent predictors of national COVID-19 incidence, mortality, and epidemic growth rate. Temperature at 5-7 weeks before the first reported case best predicted epidemic growth, suggesting that significant community transmission was occurring on average 1-2 months prior to detection. Interpretation. The results of this ecologic analysis demonstrate that global COVID-19 burden and timing of country-level epidemic growth can be predicted by weather and population factors. In particular, we find that cool, dry, and higher altitude environments, as well as more urban and obese populations, may be conducive to more rapid epidemic spread. Funding sources: None.","rel_num_authors":3,"rel_authors":[{"author_name":"Nicole Y. Leung","author_inst":"Stanford University School of Medicine"},{"author_name":"Michelle A. Bulterys","author_inst":"University of Washington International Clinical Research Center"},{"author_name":"Philip L. Bulterys","author_inst":"Stanford University School of Medicine"},{"author_name":"Ronan Foley","author_inst":"Maynooth University"},{"author_name":"Michael G Baker","author_inst":"University of Otago, Wellington"},{"author_name":"Martin Eichner","author_inst":"Epimos"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.05.14.20100909","rel_title":"Rapid estimation of excess mortality in times of COVID-19 in Portugal - Beyond reported deaths","rel_date":"2020-05-19","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.05.14.20100909","rel_abs":"Background: One month after the first COVID-19 infection was recorded, Portugal counted 18 051 cases and 599 deaths from COVID-19. To understand the overall impact on mortality of the pandemic of COVID-19, we estimated the excess mortality registered in Portugal during the first month of the epidemic, from March 16 until April 14 using two different methods. Methods: We compared the observed and expected daily deaths (historical average number from daily death registrations in the past 10 years) and used 2 standard deviations confidence limit for all-cause mortality by age and specific mortality cause, considering the last 6 years. An adapted ARIMA model was also tested to validate the estimated number of all-cause deaths during the study period. Results: Between March 16 and April 14, there was an excess of 1,255 all-cause deaths, 14% more than expected. The number of daily deaths often surpassed the 2 standard deviations confidence limit. The excess mortality occurred mostly in people aged 75+. Forty-nine percent (49%) of the estimated excess deaths were registered as due to COVID-19, The other 51% registered as other natural causes. Conclusion: Even though Portugal took early containment measures against COVID-19, and the population complied massively with those measures, there was significant excess mortality during the first month of the pandemic, mostly among people aged 75+. Only half of the excess mortality was registered as directly due do COVID-19.","rel_num_authors":4,"rel_authors":[{"author_name":"Andre Vieira Sr.","author_inst":"National School of Public Health"},{"author_name":"Vasco Ricoca Peixoto Sr.","author_inst":"NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Portugal"},{"author_name":"Pedro Aguiar Sr.","author_inst":"NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Portugal"},{"author_name":"Alexandre Abrantes","author_inst":"NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Portugal"},{"author_name":"Michael G Baker","author_inst":"University of Otago, Wellington"},{"author_name":"Martin Eichner","author_inst":"Epimos"},{"author_name":"Kaori Sato","author_inst":"Hokkaido University"},{"author_name":"Satoshi Oguri","author_inst":"Hokkaido University"},{"author_name":"Keisuke Taki","author_inst":"Hokkaido University"},{"author_name":"Hajime Senjo","author_inst":"Hokkaido University"},{"author_name":"Kasumi Hayasaka","author_inst":"Hokkaido University"},{"author_name":"Junichi Sugita","author_inst":"Hokkaido University"},{"author_name":"Satoshi Konno","author_inst":"Hokkaido University"},{"author_name":"Mutsumi Nishida","author_inst":"Hokkaido University"},{"author_name":"Takanori Teshima","author_inst":"Hokkaido University"},{"author_name":"COVID-19 Control Group","author_inst":""},{"author_name":"COVID-19 Clinical Group","author_inst":""},{"author_name":"Lucia Pareja-Cebrian","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Andrew Welch","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Joanne Field","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Brendan A.I. Payne","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Yusri Taha","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"David A. Price","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher Gibbins","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Matthias L. Schmid","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Ewan Hunter","author_inst":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"author_name":"Christopher J.A. Duncan","author_inst":"Translational and Clinical Research Institute, Newcastle University, UK"},{"author_name":"Kate Bailey","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Richard Dillon","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Matthew Streetly","author_inst":"Guy's and St Thomas' NHS Foundation Trust"},{"author_name":"Anna Rigg","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Richard Sullivan","author_inst":"King's College London"},{"author_name":"Saoirse Dolly","author_inst":"Guy's and St. Thomas NHS Foundation Trust"},{"author_name":"Mieke Van Hemelrijck","author_inst":"King's College London"},{"author_name":"Jocelyn Dachary","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabien Brulport","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Adrian Gonzalez","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Olivier Dehaene","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Baptiste Schiratti","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Kathryn Schutte","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Jean-Christophe Pesquet","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Hugues Talbot","author_inst":"Centre de Vision Num\u00e9rique, Universit\u00e9 Paris-Saclay, CentraleSup\u00e9lec, Inria, 91190 Gif-sur-Yvette, France"},{"author_name":"Elodie Pronier","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Gilles Wainrib","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Thomas Clozel","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"},{"author_name":"Fabrice Barlesi","author_inst":"D\u00e9partement d'Oncologie M\u00e9dicale, Gustave Roussy, Universit\u00e9 Paris-Saclay, Villejuif, F-94805, France"},{"author_name":"Marie-France Bellin","author_inst":"Radiology Department, H\u00f4pital de Bic\u00eatre, AP-HP, Universit\u00e9 Paris Saclay, Le Kremlin-Bic\u00eatre, France"},{"author_name":"Michael G. B. Blum","author_inst":"Owkin Lab, Owkin, Inc. New York, NY USA"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"public and global health"}]}



